Correlation of gross tumor volume excursion with potential benefits of respiratory gating.

PURPOSE To test the hypothesis that the magnitude of thoracic tumor motion can be used to determine the desirability of respiratory gating. METHODS AND MATERIALS Twenty patients to be treated for lung tumors had computed tomography image data sets acquired under assisted breath hold at normal inspiration (100% tidal volume), at full expiration (0% tidal volume), and under free breathing. A radiation oncologist outlined gross tumor volumes (GTVs) on the breath-hold computed tomographic images. These data sets were registered to the free-breathing image data set. Two sets of treatment plans were generated: one based on an internal target volume explicitly formed from assessment of the excursion of the clinical target volume (CTV) through the respiratory cycle, representing an ungated treatment, and the other based on the 0% tidal volume CTV, representing a gated treatment with little margin for residual motion. Dose-volume statistics were correlated to the magnitude of the motion of the center of the GTV during respiration. RESULTS Patients whose GTVs were >100 cm(3) showed little decrease in lung dose under gating. The other patients showed a correlation between the excursion of the center of the GTV and a reduction in potential lung toxicity. As residual motion increased, the benefits of respiratory gating increased. CONCLUSION Gating seems to be advantageous for patients whose GTVs are <100 cm(3) and for whom the center of the GTV exhibits significant motion, provided residual motion under gating is kept small.

[1]  George Starkschall,et al.  Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part I--correlating internal lung motion with skin fiducial motion. , 2004, International journal of radiation oncology, biology, physics.

[2]  H. Shirato,et al.  Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. , 2000, International journal of radiation oncology, biology, physics.

[3]  José Belderbos,et al.  Biology contributionComparing different NTCP models that predict the incidence of radiation pneumonitis , 2003 .

[4]  George Starkschall,et al.  Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription. , 2003, International journal of radiation oncology, biology, physics.

[5]  J C Rosenwald,et al.  Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.

[6]  G J Kutcher,et al.  Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. , 1999, International journal of radiation oncology, biology, physics.

[7]  Icru Prescribing, recording, and reporting photon beam therapy , 1993 .

[8]  Andrew Jackson,et al.  Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. , 2002, International journal of radiation oncology, biology, physics.

[9]  M. Halliwell,et al.  Ultrasound quantitation of respiratory organ motion in the upper abdomen. , 1994, The British journal of radiology.

[10]  R C Grimm,et al.  Respiratory kinematics of the upper abdominal organs: A quantitative study , 1992, Magnetic resonance in medicine.

[11]  J. Wong,et al.  The use of active breathing control (ABC) to reduce margin for breathing motion. , 1999, International journal of radiation oncology, biology, physics.

[12]  Daniel A. Bassano,et al.  A dwell position verification method for high dose rate brachytherapy , 2004, Journal of applied clinical medical physics.

[13]  W. Stanford,et al.  Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. , 1990, International journal of radiation oncology, biology, physics.

[14]  G Starkschall,et al.  Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function. , 2001, International journal of radiation oncology, biology, physics.

[15]  M. V. van Herk,et al.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[16]  H. Kubo,et al.  Respiration gated radiotherapy treatment: a technical study. , 1996, Physics in medicine and biology.

[17]  Shinichi Shimizu,et al.  Real-time tumour-tracking radiotherapy , 1999, The Lancet.

[18]  Joos V Lebesque,et al.  Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. , 2003, International journal of radiation oncology, biology, physics.

[19]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[20]  M. V. van Herk,et al.  Physical aspects of a real-time tumor-tracking system for gated radiotherapy. , 2000, International journal of radiation oncology, biology, physics.